EMCURE.NS(EMCURE.NS)
EMCURE.NS
No analyst ratings available
No analyst price targets available for EMCURE.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $104.40B | $117.03B | $129.11B |
| Low | $104.02B | $115.23B | $127.83B |
| High | $104.94B | $118.98B | $130.56B |
| EBITDA Avg | $20.14B | $22.58B | $24.91B |
| Low | $20.07B | $22.23B | $24.66B |
| High | $20.25B | $22.96B | $25.19B |
| EBIT Avg | $15.22B | $17.06B | $18.82B |
| Low | $15.16B | $16.80B | $18.64B |
| High | $15.30B | $17.35B | $19.03B |
| Net Income Avg | $11.52B | $14.15B | $17.70B |
| Low | $11.13B | $13.02B | $17.47B |
| High | $11.71B | $14.97B | $17.95B |
| EPS Avg | $60.78 | $74.65 | $93.36 |
| Low | $58.74 | $68.70 | $92.16 |
| High | $61.79 | $79.00 | $94.73 |
| Analysts (Rev / EPS) | 6 / 6 | 6 / 6 | 5 / 4 |